PRAP study—partial versus radical adrenalectomy in hereditary pheochromocytomas
Kai Xu(Radboud University Nijmegen), Joanne M. de Laat(Radboud University Nijmegen), Tessa M. van Ginhoven(Erasmus MC), Schelto Kruijff(University Medical Center Groningen), Rebecca V. Steenaard(Radboud University Nijmegen), Marieke Velema(Slingeland Ziekenhuis), Koen M.A. Dreijerink(University Medical Center Utrecht), Yasir Elhassan(University Hospitals Birmingham NHS Foundation Trust), Charlotte Lussey‐Lepoutre(Inserm), Richard A. Feelders(Erasmus MC), Henri Timmers(Radboud University Nijmegen), Nicole Bechmann(University Hospital Carl Gustav Carus), Charlotte L. Viëtor(Erasmus MC Cancer Institute), Wouter T. Zandee(University Medical Center Groningen), Letizia Canu(Azienda Ospedaliero-Universitaria Careggi), Natacha Driessens(Université Libre de Bruxelles), Samuel Backman(Uppsala University), Fabio Bioletto(Department of Medical Sciences), Anton F. Engelsman(The University of Sydney), Johan F. Langenhuijsen(Radboud University Nijmegen), Mirko Parasiliti‐Caprino(University of Turin), Tobias Åkerström(Uppsala University), Christina Pamporaki(University Hospital Carl Gustav Carus)
Cited by 8
Related Papers
Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival
|Journal of Clinical Oncology|2008|1.4k
Radiolabeled Somatostatin Analog [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors
|Journal of Clinical Oncology|2005|659
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors
|Clinical Cancer Research|2017|604
Natural History of Adrenal Incidentalomas With and Without Mild Autonomous Cortisol Excess
|Annals of Internal Medicine|2019|247
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study
|The Lancet Diabetes & Endocrinology|2020|247